Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Lucid Diagnostics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Lucid Diagnostics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Matheis Dennis | Director | 1,033,443 | May 21, 2026 | 2 |
| Palumbo John R | Director | 338,000 | Feb 24, 2026 | 2 |
| McGrath Dennis M | Chief Financial Officer | 1,813,569 | Feb 24, 2026 | 1 |
| Sokolov Jacque J | Director | 320,460 | Feb 24, 2026 | 1 |
| Aklog Lishan | Chief Executive Officer | 3,636,627 | Feb 24, 2026 | 1 |
| Sparks Ronald M | Director | 320,460 | Feb 24, 2026 | 1 |
| Cox James L | Director | 405,120 | Feb 24, 2026 | 1 |
| Lapidus Stanley | Director | 337,392 | Feb 24, 2026 | 1 |
| White Debra | Director | 235,800 | Feb 24, 2026 | 1 |
| O'Neil Shaun | President and COO | 1,446,763 | Feb 24, 2026 | 1 |
| Gordon Michael Adam | General Counsel and Secretary | 1,000,000 | Feb 24, 2026 | 1 |
| PAVmed Inc. | 10% Owner | 31,302,444 | Feb 20, 2024 | 0 |
| Angagaw Aster | Director | – | Feb 23, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 (view filing) | May 20 | 1 day | Matheis DennisDirector | PPurchase | +245.0K | $1.00 | +$245.0K | +31.1%1.03M after | |
| Aug 22, 2025 (view filing) | Aug 20 | 2 days | Matheis DennisDirector | PPurchase | +100.0K | $1.02 | +$102.0K | +17.7%665.4K after | |
| May 23, 2025 (view filing) | May 20-22 | 3 days | Matheis DennisDirector | PPurchase | +350.0K | $1.31 | +$458.3K | +162.5%565.4K after | Amended3 lots |
| Sep 27, 2023 (view filing) | Sep 25-26 | 2 days | Lapidus StanleyDirector | SSale | −29.9K | $1.45 | −$43.4K | −22.8%101.6K after | 4 lots10b5-1 |
| Sep 27, 2023 (view filing) | Sep 20-21 | 7 days | Lapidus StanleyDirector | SSale | −3.92K | $1.45 | −$5.67K | −2.9%131.5K after | Amended3 lots10b5-1 |
| Sep 22, 2022 (view filing) | Sep 20 | 2 days | Lapidus StanleyDirector | SSale | −33.9K | $1.71 | −$57.7K | −20.0%135.5K after | 2 lots |
| Oct 20, 2021 (view filing) | Oct 18 | 2 days | PAVmed Inc.10% Owner | PPurchase | +571.4K | $14.00 | +$8.00M | +2.1%27.9M after |